RABEX-5 plays an oncogenic role in breast cancer by activating MMP-9 pathway

Journal of Experimental and Clinical Cancer Research

Volumn 32, Issue 1, 2013, Pages

  Zhang, Xiang ^a   Min, Jie ^a   Wang, Yingjian ^a   Li, Yan ^a   Li, Hongzhong ^a   Liu, Qiang ^a   Liang, Xinjie ^a   Mu, Peng ^a   Li, Hongyuan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Oncogene; RABEX 5; RNAi

Indexed keywords

GELATINASE B; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PROTEIN RABEX5; RAB PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXILLARY LYMPH NODE; BREAST; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST METASTASIS; CANCER CELL CULTURE; CANCER PROGNOSIS; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 7; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME REGULATION; EX VIVO STUDY; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR GROWTH; TUMOR VOLUME; WESTERN BLOTTING;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HETEROGRAFTS; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; MCF-7 CELLS; MICE; MICE, NUDE; ONCOGENES; RNA INTERFERENCE;

EID: 84881308911     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-32-52     Document Type: Article

References (30)

1. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA Cancer J Clin 2011 61 69 90 10.3322/caac.20107 21296855
2. Worldwide cervical and uterine cancer incidence and mortality, 2002. Stat bite, J Natl Cancer Inst 2006 98 1031 16882937
3. Ras oncogenes and their downstream targets. Rajalingam K, Schreck R, Rapp UR, Albert S, Biochim Biophys Acta 2007 1773 1177 1195 10.1016/j.bbamcr.2007. 01.012 17428555
4. Rho GTPases in cell biology. Etienne-Manneville S, Hall A, Nature 2002 420 629 635 10.1038/nature01148 12478284
5. GAP control: regulating the regulators of small GTPases. Bernards A, Settleman J, Trends Cell Biol 2004 14 377 385 10.1016/j.tcb.2004.05.003 15246431
6. Rho GTPases and their effector proteins. Bishop AL, Hall A, Biochem J 2000 348 241 255 10.1042/0264-6021:3480241 10816416
7. Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis? Repasky GA, Chenette EJ, Der CJ, Trends Cell Biol 2004 14 639 647 10.1016/j.tcb.2004.09.014 15519853
8. The Ras superfamily at a glance. Wennerberg K, Rossman KL, Der CJ, J Cell Sci 2005 118 843 846 10.1242/jcs.01660 15731001
9. Integrin-mediated function of Rab GTPases in cancer progression. Subramani D, Alahari SK, Mol Cancer 2010 9 312 10.1186/1476-4598-9-312 21143914
10. Rab GTPases as coordinators of vesicle traffic. Stenmark H, Nat Rev Mol Cell Biol 2009 10 513 525 19603039
11. Enhanced expression of Rab27A gene by breast cancer cells promoting invasiveness and the metastasis potential by secretion of insulin-like growth factor-II. Wang JS, Wang FB, Zhang QG, Shen ZZ, Shao ZM, Mol Cancer Res 2008 6 372 382 10.1158/1541-7786.MCR-07-0162 18337447
12. Rab proteins as membrane organizers. Zerial M, McBride H, Nat Rev Mol Cell Biol 2001 2 107 117 10.1038/35052055 11252952
13. A novel RAB-5 GDP/GTP exchange factor complexed to Rabaptin-5 links nucleotide exchange to effector recruitment and function. Horiuchi H, Lippe R, McBride HM, Rubino M, Woodman P, Stenmark H, Rybin V, Wilm M, Ashman K, Mann M, et al. Cell 1997 90 1149 1159 10.1016/S0092-8674(00)80380-3 9323142
14. Seven genes that are differentially transcribed in colorectal tumor cell lines. Nimmrich I, Erdmann S, Melchers U, Finke U, Hentsch S, Moyer MP, Hoffmann I, Muller O, Cancer Lett 2000 160 37 43 10.1016/S0304-3835(00)00553-X 11098082
15. A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area. Xavier LL, Viola GG, Ferraz AC, Da Cunha C, Deonizio JM, Netto CA, Achaval M, Brain Res Brain Res Protoc 2005 16 58 64 10.1016/j.brainresprot.2005.10.002 16310404
16. Matrix metalloproteinases: regulators of the tumor microenvironment. Kessenbrock K, Plaks V, Werb Z, Cell 2010 141 1 52 67 10.1016/j.cell.2010.03.015 20371345
17. RAB-5 controls early endosome fusion in vitro. Gorvel JP, Chavrier P, Zerial M, Gruenberg J, Cell 1991 64 915 925 10.1016/0092-8674(91)90316-Q 1900457
18. Biochemical and functional characterization of a recombinant GTPase, RAB-5, and two of its mutants. Hoffenberg S, Sanford JC, Liu S, Daniel DS, Tuvin M, Knoll BJ, Wessling-Resnick M, Dickey BF, J Biol Chem 1995 270 5048 5056 10.1074/jbc.270.10.5048 7890612
19. The small GTPase RAB-5 functions as a regulatory factor in the early endocytic pathway. Bucci C, Parton RG, Mather IH, Stunnenberg H, Simons K, Hoflack B, Zerial M, Cell 1992 70 715 728 10.1016/0092-8674(92)90306-W 1516130
20. Structural features of the GTP-binding defective RAB-5 mutants required for their inhibitory activity on endocytosis. Li G, Barbieri MA, Colombo MI, Stahl PD, J Biol Chem 1994 269 14631 14635 8182071
21. Phosphate-binding loop and Rab GTPase function: mutations at Ser29 and Ala30 of RAB-5 lead to loss-of-function as well as gain-of-function phenotype. Li G, Liang Z, Biochem J 2001 355 681 689 11311130
22. Effectors of GTPase RAB-5 in endocytosis and signal transduction. Olchowik M, Miaczynska M, Postepy Biochem 2009 55 171 180 19824473
23. RAB-5A is associated with axillary lymph node metastasis in breast cancer patients. Yang PS, Yin PH, Tseng LM, Yang CH, Hsu CY, Lee MY, Horng CF, Chi CW, Cancer Sci 2011 102 2172 2178 10.1111/j.1349-7006.2011.02089.x 21895870
24. RAB-5a overexpression promoting ovarian cancer cell proliferation may be associated with APPL1-related epidermal growth factor signaling pathway. Zhao Z, Liu XF, Wu HC, Zou SB, Wang JY, Ni PH, Chen XH, Fan QS, Cancer Sci 2010 101 1454 1462 10.1111/j.1349-7006.2010.01558.x 20412119
25. RAB-5 mediates caspase-8-promoted cell motility and metastasis. Torres VA, Mielgo A, Barbero S, Hsiao R, Wilkins JA, Stupack DG, Mol Biol Cell 2010 21 369 376 10.1091/mbc.E09-09-0769 19923319
26. Unlocking the potential of the human genome with RNA interference. Hannon GJ, Rossi JJ, Nature 2004 431 371 378 10.1038/nature02870 15372045
27. Gelatinase-mediated migration and invasion of cancer cells. Bjorklund M, Koivunen E, Biochim Biophys Acta 2005 1755 37 69 15907591
28. Localizing matrix metalloproteinase activities in the pericellular environment. Murphy G, Nagase H, FEBS J 2011 278 2 15 10.1111/j.1742-4658.2010. 07918.x 21087456
29. Regulation of matrix metalloproteinase activity in health and disease. Hadler-Olsen E, Fadnes B, Sylte I, Uhlin-Hansen L, Winberg JO, FEBS J 2011 278 28 45 10.1111/j.1742-4658.2010.07920.x 21087458
30. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, et al. Nat Cell Biol 2000 2 737 744 10.1038/35036374 11025665